Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Long-Term Debt Issuances (2020 - 2022)

Historic Long-Term Debt Issuances for Aytu Biopharma (AYTU) over the last 10 years, with Q1 2022 value amounting to -$73.9 million.

  • Aytu Biopharma's Long-Term Debt Issuances changed N/A to -$73.9 million in Q1 2022 from the same period last year, while for Jun 2022 it was $15.0 million, marking a year-over-year change of. This contributed to the annual value of $1.9 million for FY2025, which is 8571.54% down from last year.
  • Latest data reveals that Aytu Biopharma reported Long-Term Debt Issuances of -$73.9 million as of Q1 2022.
  • In the past 5 years, Aytu Biopharma's Long-Term Debt Issuances registered a high of $46.6 million during Q4 2021, and its lowest value of -$73.9 million during Q1 2022.
  • Over the past 3 years, Aytu Biopharma's median Long-Term Debt Issuances value was $2.5 million (recorded in 2020), while the average stood at $3.6 million.